Try our business solution for free!

Impact of COVID-19 pandemic on U.S. liaisons/clinical engagement 2020

Published by
Matej Mikulic,
Dec 12, 2022
According to a survey conducted among health provider executives and pharma/lif sciences executives in August-September 2020, 56 percent of provider executives said that the COVID-19 pandemic somewhat negatively impacted medical science liaisons engagement with clinicians. This statistic illustrates the impact of the COVID-19 pandemic on the engagement between U.S. medical science liaisons and clinicians.

Negative impact of COVID-19 on engagement between U.S. medical science liaisons and clinicians as of 2020

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2020

Region

United States

Survey time period

August 21 to September 10, 2020

Number of respondents

153 provider, 124 pharmaceutical and life sciences executives

Method of interview

Online survey

Supplementary notes

Original question: "How negatively or positively has the COVID-19 pandemic affected engagement between medical science liaisons and clinicians?"

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical research and development "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical research and development

Overview

6

R&D performance by company

5

Characteristics of R&D pipeline

5

Costs and ROI

4

Outsourced R&D

5

Opinions on pharma R&D

6

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu